Associated with risk of liver damage and hepatic failure.
It is recommended to monitor the serum aminotransferase before therapy and every two weeks on treatment.
Views: 5
Categories
Standard of CareStandard of CareAssociated with risk of liver damage and hepatic failure.
It is recommended to monitor the serum aminotransferase before therapy and every two weeks on treatment.